Paik Younkee, Yang Chao, Metaferia Belhu, Tang Shoubin, Bane Susan, Ravindra Rudravajhala, Shanker Natasha, Alcaraz Ana A, Johnson Scott A, Schaefer Jacob, O'Connor Robert D, Cegelski Lynette, Snyder James P, Kingston David G I
Department of Chemistry, M/C 0212, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061, USA.
J Am Chem Soc. 2007 Jan 17;129(2):361-70. doi: 10.1021/ja0656604.
The important anticancer drug Taxol (paclitaxel, PTX) owes its unique activity to its ability to bind to tubulin in a stoichiometric ratio and promote its assembly into microtubules. The conformation of the microtubule-bound drug has been the focus of numerous research efforts, since the inability of polymerized tubulin to form crystals precludes structure proof by X-ray crystallography. Likewise, although the alpha,beta-tubulin dimer structure has been solved by electron crystallography, the 3.7 A resolution is too low to permit direct determination of either ligand conformation or binding pose. In this article, we present experimental results from 2H{19F} REDOR NMR that provide direct confirmation that paclitaxel adopts a T-shaped conformation when it is bound to tubulin.
重要的抗癌药物紫杉醇(paclitaxel,PTX)因其能够以化学计量比与微管蛋白结合并促进其组装成微管而具有独特活性。由于聚合的微管蛋白无法形成晶体,从而排除了通过X射线晶体学确定结构的可能性,因此与微管结合的药物构象一直是众多研究工作的重点。同样,尽管α,β-微管蛋白二聚体结构已通过电子晶体学解析,但3.7埃的分辨率太低,无法直接确定配体构象或结合姿态。在本文中,我们展示了2H{19F} REDOR NMR的实验结果,这些结果直接证实了紫杉醇与微管蛋白结合时采用T形构象。